№ lp_1_35691
File format: docx Character count: 26060 File size: 62 KB
Dapagliflozin/metformin XR FDC is a pharmaceutical submission requesting Authority Required listing for the treatment of type 2 diabetes in Australia.
Year: 2014
Region / city: Australia
Topic: Pharmaceutical product submission
Document type: Application for listing
Organization / institution: Pharmaceutical Benefits Advisory Committee (PBAC)
Author: AstraZeneca Pty Ltd
Target audience: Health professionals, regulatory authorities
Period of validity: Not specified
Approval date: Not specified
Date of changes: 1 April 2014
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.